A proposed preamble to informed consent documents

Pediatric Blood and Cancer

Volumn 55, Issue 1, 2010, Pages 14-15

  Masera, Giuseppe ^a   D'Angio, Giulio ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; INFORMED CONSENT; MEDICAL DOCUMENTATION; MEDICAL INFORMATION SYSTEM; NOTE; PRIORITY JOURNAL; TREATMENT PLANNING;

CONSENT FORMS; HUMANS; INFORMED CONSENT; PARENTS; PHYSICIAN-PATIENT RELATIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77953271124     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22556     Document Type: Note

References (5)

1. Evans AE. The myth of informed consent. J Ped Hematol Oncol 2001;23:74.
2. Berger O, Grønberg BH, Sand K, et al. The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol 2009;20:379-385.
3. Beardsley E, Jefford M, Mileshkin L. Longer consent forms for clinical trials compromise patient understanding: So why are they lengthening? J Clin Oncol 2007;25:e13-e14.
4. Wiley FM, Ruccione K, Moore IM, et al. Parents' perceptions of randomization in pediatric clinical trials cancer practice. 1999;7:248-256.
5. Jefford M, Moore R. Improvement of informed consent and the quality of consent documents. Lancet Oncol 2008;9:485-493. (Pubitemid 351597797)